![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Dr. Jose Oberholzer
Dr. Oberholzer was Head of the Islet Transplant Program at the University of Geneva and the GRAGIL islet consortium from 1998 to 2002, completing a significant number of islet transplants. He has headed UIC's Islet Transplant Program since 2003, and is Chief of the UIC Division of Transplantation since Summer 2007. UIC has a comprehensive multi-organ transplant program with emphasis on transplantation for diabetes as well as robotic surgery in living donors for kidney, liver, pancreas and small bowel. Dr. Oberholzer is an expert in advanced minimally invasive and robotic surgery of abdominal organs. UIC is a federally funded islet cell resource center that prepares islets for researchers around the world. By January 2008, UIC islet isolation teams performed over 250 human islet isolations for both transplant and research. Dr. Oberholzer has successfully completed a phase 1/2 clinical trial with 10 patients to investigate the effect of anti-inflammatory treatment combined with exenatide on islet transplantation outcomes at UIC. Presently, the UIC islet team is collaborating with Dr. Ricordi and Dr. Alejandro at the University of Miami to investigate the effect of glucagon-like peptides on islet transplant outcomes and strategies to improve the survival of islets after transplantation. University of Illinois at Chicago Return to Who is in the CIT Consortium
|
Home | |
![]() ![]() ![]() ![]() |